Detlef Grawe
11Patents
4h-index
30Co-inventors
56Inventor score
Filing activity: Jul 29, 1998 → Mar 30, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6902741B1 | Laminates containing an active substance transdermal system | Human Necessities | 17 | Expired |
| US6063404A | Bioadhesive tablet | Human Necessities | 13 | Expired |
| US7192942B2 | Process for production of crystals of 11μ-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them | Human Necessities | 6 | Expired |
| US7799770B2 | Solid body forms of mesoprogestin 11β-{4E-(hydroxyiminomethyl)-phenyl}-17α methoxymethyl-17β-methoxy-estra-4,9-dien-3-one | Chemistry; Metallurgy | 6 | Active |
| US7148212B2 | Process for production of steroid crystals, steroid crystals obtained thereby and pharmaceutical preparations containing them | Human Necessities | 1 | Expired |
| US6290931A | Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations | Human Necessities | 1 | Expired |
| US8324412B2 | Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil) | Emerging Cross-Sectional Technologies | 0 | Active |
| US6974885B2 | Method for isolating pharmaceutically exploitable etidronate disodium | Chemistry; Metallurgy | 0 | Expired |
| US9211485B2 | Method for producing crystalline active ingredient particles | Emerging Cross-Sectional Technologies | 0 | Active |
| US9173843B2 | Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs | Electricity | 0 | Active |
| US9095783B2 | Arrangement and method for producing high-purity crystals | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.